SCHEMBL24252035

SCHEMBL24252035

CNC(=O)c1ccc(Cl)c(C(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.47
KDM4E B2RXH2 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC2 Q92769 1/20 0.44
PYGL P06737 1/20 0.44
PLAU P00749 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GRN P28799 1/20 0.42
SORT1 Q99523 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 3/20 0.41
SLC6A3 Q01959 3/20 0.41
HSP90AA1 P07900 1/20 0.41
PLK1 P53350 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19346306 0.81 HTT (0.48) HPGDHDAC8HDAC6HDAC2PLAU
SCHEMBL12125525 0.80 TSHR (0.59) KDM4ESMN1; SMN2TSHRMEN1NPC1
SCHEMBL12435335 0.80 MAPT (0.43) HPGDSMN1; SMN2LMNATSHRHTT
SCHEMBL4161973 0.80 MEN1 (0.61) HPGDKDM4EHDAC8HDAC6HDAC2
SCHEMBL19766503 0.79 HDAC6 (0.45) HPGDHDAC8HDAC6HDAC2PLAU
SCHEMBL22000399 0.79 ALDH1A1 (0.55) HPGDKDM4ESMN1; SMN2LMNATSHR
SCHEMBL22424262 0.79 PLAU (0.46) HPGDKDM4EHDAC8HDAC6HDAC2
SCHEMBL12125516 0.79 PARP1 (0.44) HPGDKDM4ESMN1; SMN2LMNATSHR
SCHEMBL2635868 0.77 GAA (0.45) HPGDSMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL19651838 0.77 TLR9 (0.51) HPGDKDM4EPYGLSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 HPGD 190/4885KDM4E 3284/4885HDAC8 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.